Finance

Beta
Lists
2M6:FRA
Medtronic PLC
€63.68
-0.09%
(-0.060) 1D
Jun 2, 11:46:34 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2M6...
Open
€63.52
High
€63.74
Low
€63.52
Mkt. cap
94.98B
Avg. vol.
1.60K
Volume
1.50K
52-wk high
€91.45
52-wk low
€63.22
No. of employees
95K
Open
€63.52
High
€63.74
Low
€63.52
Mkt. cap
94.98B
Avg. vol.
1.60K
Volume
1.50K
52-wk high
€91.45
52-wk low
€63.22
No. of employees
95K
News stories
From sources across the web
Profile
Medtronic plc is an American-Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
About Medtronic PLC
CEOGeoffrey S. Martha
Employees95K
Founded1949
Headquarters-
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
8.93B
8.58B
8.96B
9.02B
Cost of goods sold
3.14B
2.98B
3.06B
3.17B
Cost of revenue
3.14B
2.98B
3.06B
3.17B
Research and development expenses
684.00M
726.00M
754.00M
722.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.70B
2.78B
2.94B
2.93B
Operating expense
4.26B
3.99B
4.08B
4.04B
Total operating expenses
7.40B
6.98B
7.14B
7.21B
Operating income
1.53B
1.60B
1.82B
1.80B
Other non operating income
7.00M
68.00M
3.00M
13.00M
EBT including unusual items
1.26B
1.30B
1.60B
1.40B
EBT excluding unusual items
1.83B
1.62B
1.68B
1.66B
Income tax expense
199.00M
255.00M
215.00M
254.00M
Effective tax rate
15.79%
19.59%
13.47%
18.10%
Other operating expenses
308.00M
72.00M
-29.00M
-79.00M
Net income
1.06B
1.04B
1.37B
1.14B
Net profit margin
11.83%
12.12%
15.33%
12.68%
Earnings per share
1.62
1.26
1.36
1.36
Interest and investment income
147.00M
120.00M
89.00M
102.00M
Interest expense
-174.00M
-176.00M
-181.00M
-181.00M
Net interest expenses
-27.00M
-56.00M
-92.00M
-79.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.22B
2.31B
2.52B
2.52B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more